Home

The Challenge of Commercializing MedTech Innovation

Commercializing a MedTech innovation requires timing, strategy, and execution—and the foundation for success must be established well before launch.

Founders and company leaders must carefully allocate limited resources to make pivotal pre-commercial decisions and develop the strategies and frameworks essential for success, all while juggling competing priorities with constrained funding and bandwidth.

Stakeholders and potential investors expect robust commercial strategies and rapid traction after launch, yet adding additional senior team members or specialized consultants can be costly and challenging to coordinate.

There is much to do, but little time and resourcing to do it all.

Keelpath Partners specializes in this demanding phase.

How can Keelpath Partners help?

Keelpath Partners helps MedTech innovators prepare for commercialization with the insight, structure, and strategies typically found in a full commercial organization—delivered efficiently and focused on results.

We partner with founders and leadership teams before and through launch, ensuring every decision and effort supports growth.

Our work focuses on the critical areas that determine commercial success:

Strategy and Roadmap – Assessing markets and defining segments to find your path; establishing the roadmap to launch and growth.
Go-to-Market Plan – Positioning your innovation, defining target markets, and creating launch and sales frameworks for planning, execution, and measurement.
Market Access and Payor Strategy – Pursuing paths for third-party payment while balancing early growth with long-term success
Business Plans and Investor Presentations – Sharing your vision and plan clearly and concisely.
Fractional Commercial Leadership – Serving as your commercial lead and partnering to resource your commercialization needs.
Advisory, KOL, and Stakeholder Engagement – Creating your network of support and partnership.
Revenue Operations – Aligning and optimizing resources, processes, and tech stacks for marketing, sales, and customer success.
Marketing and Communications – Creating infrastructure and developing company branding and messaging; collaborating with vendors to assure alignment with overall strategy.

At Keelpath Partners, we help MedTech innovators focus limited resources where they matter most — turning innovation into sustainable commercial momentum.

Keelpath Partners Founder and Principal Consultant, Andy Dolan, is an accomplished medtech leader with a 25-year track record of driving revenue growth, organizational expansion, and stakeholder value for medtech companies. He leverages deep expertise in commercialization, marketing, and market access to consistently deliver impactful, measurable results.

He has held leadership positions at startups such as CIONIC, ONWARD Medical, and ReWalk Robotics (now Lifeward). These companies raised over $200M during his tenure on their executive teams, including two IPOs. Before these roles, he developed his career in sales and marketing at Boston Scientific, Johnson & Johnson, and Integra LifeSciences.

He holds a BS from Springfield College, an MBA from the University of Massachusetts Amherst, and a graduate certificate in bioengineering from Tufts University. Additionally, he serves as a Public Affairs Officer in the United States Navy.

Navigating a Course to Medtech Commercial Success

Andy Dolan

Why Keelpath Partners?

Get in Touch with Keelpath

Contact